Meet Our Consultants
The world's greatest minds finding solutions to your challenges
Below is a small selection of the academics and researchers from the University of Oxford who carry out consultancy through OUC. Contact us to find the ideal consultant for your company challenges.
Dr Russell Layberry
Russell Layberry has 15 years research experience, ten of which are in Environmental Computational Physics. Previous positions have been involved in Plasma Physics and Semiconductor Engineering, Glaciology, Climatology and Energy Studies. His current interests include energy demand in the residential and non-residential sectors, building energy modelling, building energy management including the production of building monitoring software, remote sensing, meteorology and climatology. Skillsets include IDL, C, Fortran and Unix programming, massive dataset analysis and data visualisation.
Dr Layberry is available to advise on all aspects of energy studies especially forecast demand, building energy systems and the effects of climatology on energy trends. He is also a leading proponent of the biochar sequestration technology.
Dr Steve New
Steve has been a lecturer in Operations Management at the Saïd Business School since 1996 and was formerly Head of Degree Programmes at the school. He has also served as Investment Bursar of Hertford College. Steve began his career as an engineer, working for Rolls Royce plc while completing a degree in physics at Southampton University. In 1988, after working in management consultancy for Collinson Grant, he went to Manchester Business School (MBS) where he completed his doctorate. Later, he taught at the Manchester School of Management.
Steve works extensively with a range of organisations in the private, public and not-for-profit sectors. His research focuses on process improvement and supply chain management. Broader interests include the application of the Toyota Production System, especially in healthcare, and in the management of product traceability.
Dr Sarah Watkinson
Dr Watkinson is an expert on fungi, specialising in the dry rot fungusSerpula lacrymans. With extensive commercial experience including directorship of an Oxford University spin-out company, she is available for decay diagnosis and reporting for building conservation.
Dr Watkinson holds the Cardiff University/Bond Solon expert witness certificate (2010) and is qualified in CPR 35-compliant reporting. She holds consultant membership of the Property Care Association. Past clients include the Property Services Agency, Scottish National Heritage, the Ministry of Defence, the University of Oxford, and numerous private clients.
Dr Watkinson is a member of the Department of Plant Sciences, University of Oxford.
Dr Paul Newman
Paul Newman obtained an MEng in Engineering Science from Oxford University in 1995. He then undertook a PhD in autonomous navigation at the Australian Center for Field Robotics, University of Sydney. In 1999 he returned to the United Kingdom to work in the commercial sub-sea navigation industry. In late 2000 he joined the Department of Ocean Engineering at M.I.T. where as a post-doc and later a research scientist, he worked on algorithms and software for robust autonomous navigation for both land and sub-sea agents.
Paul is currently a Reader in Engineering Science at Oxford, heading-up the Oxford Mobile Robotics Research group. He is on the editorial board of the International Journal of Robotics Research and The Journal of Field Robotics and a IEEE R.A.S European Distinguished Lecturer for 2008 and 2009 and a IEEE Technical Expert on robotics.
Paul’s research and consultancy interests cover mobile robotics and autonomous vehicle navigation.
Dr Paul Emsley
Having completed his PhD in 1992 at the University of York, Dr Emsley currently holds a Research Fellowship at the Department of Biochemistry, University of Oxford.
His research is primarily focussed on providing new algorithms and tools for molecular modelling of proteins, model-fitting to X-ray data, and in developing tools for use in structure-based drug design.
Dr Emsley is the primary developer of the renowned software program, 'COOT'. Over the past 5 years, COOT has gained considerable popularity as a means to build, validate and manipulate macromolecular models. COOT is particularly popular in the pharmaceutical sector as it can be easily tailored to suit their specific needs in short timescales, allowing, for instance, the turnaround of 3D target-ligand structures in just a few days. Paul provides pharmaceutical clients with guidance on how best to use COOT to solve their specific challenges in drug design.
Dr Carl Henegan
Carl Heneghan is Deputy Director of the Centre for Evidence-Based Medicine (EBM). He is a General Practitioner and Senior Clinical Research Fellow in the Department of Primary Health Care at the University of Oxford.
Carl has considerable experience in teaching EBM practice, both in the academic and commercial sector through consultancy. He co-authored the EBM Toolkits (published by BMJ) and is involved in work that promotes the understanding and teaching of critical appraisal. Carl's research interests include chronic disease management and self-monitoring in chronic diseases. He is a principal investigator in the National Institute of Heath Research unit for monitoring in chronic disease and works with the Oxford Vascular Study (OXVASC) and is a co-director of the Oxford Diagnostic Horizon Scanning Centre, an effective early warning system that identifies innovations in the field of health technology likely to have a significant impact.
Carl is currently a reviewer for the Department of Health, NIHR Health Technology Assessment (HTA) Programme review board and is a member of the Pharmaceutical Panel, is Resource review editor with the Journal of Evidence-Based Medicine and is on the Advisory Boards of the Healthcare Compliance Packaging Council (HCPC), National Knowledge Decision Support Board and the BMJ Evidence Centre.
Carl and his co-workers are able to provide consultancy advice to help organizations better understand how EBM impacts on healthcare and the implementation and development of new technologies
